339 related articles for article (PubMed ID: 22396390)
1. Suppression of protein aggregation by chaperone modification of high molecular weight complexes.
Labbadia J; Novoselov SS; Bett JS; Weiss A; Paganetti P; Bates GP; Cheetham ME
Brain; 2012 Apr; 135(Pt 4):1180-96. PubMed ID: 22396390
[TBL] [Abstract][Full Text] [Related]
2. Huntington's disease: fighting on many fronts.
Andre R; Wild EJ; Tabrizi SJ
Brain; 2012 Apr; 135(Pt 4):998-1001. PubMed ID: 22427330
[No Abstract] [Full Text] [Related]
3. Polyglutamine length-dependent interaction of Hsp40 and Hsp70 family chaperones with truncated N-terminal huntingtin: their role in suppression of aggregation and cellular toxicity.
Jana NR; Tanaka M; Wang Gh; Nukina N
Hum Mol Genet; 2000 Aug; 9(13):2009-18. PubMed ID: 10942430
[TBL] [Abstract][Full Text] [Related]
4. Six-month partial suppression of Huntingtin is well tolerated in the adult rhesus striatum.
Grondin R; Kaytor MD; Ai Y; Nelson PT; Thakker DR; Heisel J; Weatherspoon MR; Blum JL; Burright EN; Zhang Z; Kaemmerer WF
Brain; 2012 Apr; 135(Pt 4):1197-209. PubMed ID: 22252996
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of voluntary physical exercise on behavioral and brain-derived neurotrophic factor expression deficits in Huntington's disease transgenic mice.
Pang TYC; Stam NC; Nithianantharajah J; Howard ML; Hannan AJ
Neuroscience; 2006 Aug; 141(2):569-584. PubMed ID: 16716524
[TBL] [Abstract][Full Text] [Related]
6. Methylene blue modulates huntingtin aggregation intermediates and is protective in Huntington's disease models.
Sontag EM; Lotz GP; Agrawal N; Tran A; Aron R; Yang G; Necula M; Lau A; Finkbeiner S; Glabe C; Marsh JL; Muchowski PJ; Thompson LM
J Neurosci; 2012 Aug; 32(32):11109-19. PubMed ID: 22875942
[TBL] [Abstract][Full Text] [Related]
7. Sensitive biochemical aggregate detection reveals aggregation onset before symptom development in cellular and murine models of Huntington's disease.
Weiss A; Klein C; Woodman B; Sathasivam K; Bibel M; Régulier E; Bates GP; Paganetti P
J Neurochem; 2008 Feb; 104(3):846-58. PubMed ID: 17986219
[TBL] [Abstract][Full Text] [Related]
8. Chaperone suppression of cellular toxicity of huntingtin is independent of polyglutamine aggregation.
Zhou H; Li SH; Li XJ
J Biol Chem; 2001 Dec; 276(51):48417-24. PubMed ID: 11606565
[TBL] [Abstract][Full Text] [Related]
9. Reduced expression of the TrkB receptor in Huntington's disease mouse models and in human brain.
Ginés S; Bosch M; Marco S; Gavaldà N; Díaz-Hernández M; Lucas JJ; Canals JM; Alberch J
Eur J Neurosci; 2006 Feb; 23(3):649-58. PubMed ID: 16487146
[TBL] [Abstract][Full Text] [Related]
10. Co-chaperones DNAJA1 and DNAJB6 are critical for regulation of polyglutamine aggregation.
Rodríguez-González C; Lin S; Arkan S; Hansen C
Sci Rep; 2020 May; 10(1):8130. PubMed ID: 32424160
[TBL] [Abstract][Full Text] [Related]
11. Orexin loss in Huntington's disease.
Petersén A; Gil J; Maat-Schieman ML; Björkqvist M; Tanila H; Araújo IM; Smith R; Popovic N; Wierup N; Norlén P; Li JY; Roos RA; Sundler F; Mulder H; Brundin P
Hum Mol Genet; 2005 Jan; 14(1):39-47. PubMed ID: 15525658
[TBL] [Abstract][Full Text] [Related]
12. Hsp70 and Hsp40 chaperones do not modulate retinal phenotype in SCA7 mice.
Helmlinger D; Bonnet J; Mandel JL; Trottier Y; Devys D
J Biol Chem; 2004 Dec; 279(53):55969-77. PubMed ID: 15494410
[TBL] [Abstract][Full Text] [Related]
13. BH3-only proteins Bid and Bim(EL) are differentially involved in neuronal dysfunction in mouse models of Huntington's disease.
García-Martínez JM; Pérez-Navarro E; Xifró X; Canals JM; Díaz-Hernández M; Trioulier Y; Brouillet E; Lucas JJ; Alberch J
J Neurosci Res; 2007 Sep; 85(12):2756-69. PubMed ID: 17387706
[TBL] [Abstract][Full Text] [Related]
14. Astrocytic expression of the chaperone DNAJB6 results in non-cell autonomous protection in Huntington's disease.
Bason M; Meister-Broekema M; Alberts N; Dijkers P; Bergink S; Sibon OCM; Kampinga HH
Neurobiol Dis; 2019 Apr; 124():108-117. PubMed ID: 30408590
[TBL] [Abstract][Full Text] [Related]
15. Oxidative stress promotes mutant huntingtin aggregation and mutant huntingtin-dependent cell death by mimicking proteasomal malfunction.
Goswami A; Dikshit P; Mishra A; Mulherkar S; Nukina N; Jana NR
Biochem Biophys Res Commun; 2006 Mar; 342(1):184-90. PubMed ID: 16472774
[TBL] [Abstract][Full Text] [Related]
16. Mutant huntingtin and glycogen synthase kinase 3-beta accumulate in neuronal lipid rafts of a presymptomatic knock-in mouse model of Huntington's disease.
Valencia A; Reeves PB; Sapp E; Li X; Alexander J; Kegel KB; Chase K; Aronin N; DiFiglia M
J Neurosci Res; 2010 Jan; 88(1):179-90. PubMed ID: 19642201
[TBL] [Abstract][Full Text] [Related]
17. Disease-related Huntingtin seeding activities in cerebrospinal fluids of Huntington's disease patients.
Lee CYD; Wang N; Shen K; Stricos M; Langfelder P; Cheon KH; Cortés EP; Vinters HV; Vonsattel JP; Wexler NS; Damoiseaux R; Frydman J; Yang XW
Sci Rep; 2020 Nov; 10(1):20295. PubMed ID: 33219289
[TBL] [Abstract][Full Text] [Related]
18. Polyglutamine expansions cause decreased CRE-mediated transcription and early gene expression changes prior to cell death in an inducible cell model of Huntington's disease.
Wyttenbach A; Swartz J; Kita H; Thykjaer T; Carmichael J; Bradley J; Brown R; Maxwell M; Schapira A; Orntoft TF; Kato K; Rubinsztein DC
Hum Mol Genet; 2001 Aug; 10(17):1829-45. PubMed ID: 11532992
[TBL] [Abstract][Full Text] [Related]
19. Mutant huntingtin causes context-dependent neurodegeneration in mice with Huntington's disease.
Yu ZX; Li SH; Evans J; Pillarisetti A; Li H; Li XJ
J Neurosci; 2003 Mar; 23(6):2193-202. PubMed ID: 12657678
[TBL] [Abstract][Full Text] [Related]
20. A critical window of CAG repeat-length correlates with phenotype severity in the R6/2 mouse model of Huntington's disease.
Cummings DM; Alaghband Y; Hickey MA; Joshi PR; Hong SC; Zhu C; Ando TK; André VM; Cepeda C; Watson JB; Levine MS
J Neurophysiol; 2012 Jan; 107(2):677-91. PubMed ID: 22072510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
